Jeff Yass’s Bone Biologics BBLG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$5.94K Buy
+11,970
New +$9.8K ﹤0.01% 13277
2023
Q1
– Sell
-36
Closed -$10.7K – 12550
2022
Q4
$10.7K Buy
+36
New +$20.3K ﹤0.01% 11929

Other funds holding BBLG

Jeff Yass's BBLG Position: Q3 2026 in Review

Jeff Yass opened a new position in Bone Biologics (BBLG) in Q3 2026: 11,970 shares worth $5.94K. The stake represents ﹤0.01% of the portfolio and ranks #13277 among its holdings. This is a return to the name: Jeff Yass previously reported a position in BBLG as recently as Q4 2022.

Jeff Yass first reported a position in BBLG in Q4 2022 and has held it in 2 quarters since. The position peaked at $10.7K in Q4 2022. 8 funds tracked by Wall St. Rank hold BBLG as of Q3 2026.

  • Jeff Yass held 11,970 shares of Bone Biologics worth $5.94K as of Q3 2026.
  • Bone Biologics was a new Jeff Yass position in Q3 2026.
  • Bone Biologics made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #13277 holding.
  • Jeff Yass first reported a position in Bone Biologics in Q4 2022 and has held it in 2 quarters since.
  • Jeff Yass's Bone Biologics position peaked at $10.7K in Q4 2022.
  • 8 funds tracked by Wall St. Rank held Bone Biologics as of Q3 2026.

Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.